Apuli Maricel sold BBIO
August 16, 2026 · Form 4 insider transaction
Apuli Maricel sold 4,714 shares of BridgeBio Pharma, Inc. at $79.86 per share, a transaction worth $376.5K. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
4,714
Price
$79.86
Total value
$376.5K
InsiderApuli Maricel
RoleOfficer
SecurityCommon Stock
Transaction codeF: Shares withheld for taxes
Transaction dateAugust 16, 2026
Filing dateAugust 18, 2026
Shares owned after122,687
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligation in connection with the vesting of 9,262 shares of Common Stock underlying the Reporting Person's RSUs.